Kaléo, a Richmond, Virginia-based pharmaceutical company, will donate 7,500 auto-injectors to the Health Department. The agency will begin distributing the Epinephrine auto-injectors in September.
“Building on its legacy of ensuring the safety of our youngest children, the Board of Health recognized the need for epinephrine auto-injectors at child care sites across the city,” said health commissioner Mary T. Bassett, M.D., M.P.H. “Anaphylaxis is a life-threatening allergic reaction, which can be treated with an epinephrine auto-injector. I am thankful to Kaléo for its generous donation to child care sites in New York City.”
The Board of Health will also require additional training for child care sites. Staff will receive extended training in areas like cognitive development, social emotional learning, family engagement, infection control, emergency response, and mental health first aid.